Clinical Trial

The Effectiveness and Safety of Resective Epilepsy Surgery for TRE

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A prospective cohort studies to identify clinical seizure control, cognitive changes, and safety in resective epilepsy surgery in patients with TSC-related drug-resistant epilepsy.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-12-12; most recent amendment 2025-01-16.
Status change: Completed → Active, Not Recruiting 2025-01-16
Status change: Recruiting → Completed 2024-05-21
Status change: Not Yet Recruiting → Recruiting 2021-01-26
Trial Details
NCT Number NCT04198181
Lead Sponsor Beijing Children's Hospital
Collaborators: Shenzhen Children's Hospital, Tiantan Hospital, Capital Medical University, Peking University People's Hospital, Guangdong 999 Brain Hospital, Xinqiao Hospital, Amry Medical University, Shandong Provincial Hospital, West China Hospital, Henan Provincial People's Hospital, Shanghai Children's Hospital, The First Medical Center of Chinese PLA General Hospital, Fourth Medical Center of PLA General Hospital, The First Affiliated Hospital of University of Science and Technology of China, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, The Second Hospital of Hebei Medical University, The First Affiliated Hospital of Shanxi Medical University, Xuanwu Hospital, Beijing, The First Hospital of Jilin University, Xiangya Hospital of Central South University, Beijing Sanbo Brain Hospital, Nanjing Medical University
Conditions Tuberous Sclerosis Complex, Epilepsy
Enrollment 200 participants
Start Date 2019-12-12
Primary Completion 2027-03-15 (estimated)
Study Completion 2027-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-01-17